Comparative evaluation of memory T cells in COVID-19 patients and the predictive role of CD4+CD8+ double positive T lymphocytes as a new marker.


Journal

Revista da Associacao Medica Brasileira (1992)
ISSN: 1806-9282
Titre abrégé: Rev Assoc Med Bras (1992)
Pays: Brazil
ID NLM: 9308586

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 20 07 2020
accepted: 20 09 2020
entrez: 17 12 2020
pubmed: 18 12 2020
medline: 29 12 2020
Statut: ppublish

Résumé

The COVID-19 pandemic has affected the entire world, posing a serious threat to human health. T cells play a critical role in the cellular immune response against viral infections. We aimed to reveal the relationship between T cell subsets and disease severity. 40 COVID-19 patients were randomly recruited in this cross-sectional study. All cases were confirmed by quantitative RT-PCR. Patients were divided into two equivalent groups, one severe and one nonsevere. Clinical, laboratory and flow cytometric data were obtained from both clinical groups and compared. Lymphocyte subsets, CD4+ and CD8+ T cells, memory CD4+ T cells, memory CD8+ T cells, naive CD4+ T cells, effector memory CD4+ T cells, central memory CD4+ T cells, and CD3+CD4+ CD25+ T cells were significantly lower in severe patients. The naive T cell/CD4 + EM T cell ratio, which is an indicator of the differentiation from naive T cells to memory cells, was relatively reduced in severe disease. Peripheral CD4+CD8+ double-positive T cells were notably lower in severe presentations of the disease (median DP T cells 11.12 µL vs 1.95 µL; p< 0.001). As disease severity increases in COVID-19 infection, the number of T cell subsets decreases significantly. Suppression of differentiation from naive T cells to effector memory T cells is the result of severe impairment in adaptive immune functions. Peripheral CD4+CD8+ double-positive T cells were significantly reduced in severe disease presentations and may be a useful marker to predict disease severity.

Sections du résumé

BACKGROUND BACKGROUND
The COVID-19 pandemic has affected the entire world, posing a serious threat to human health. T cells play a critical role in the cellular immune response against viral infections. We aimed to reveal the relationship between T cell subsets and disease severity.
METHODS METHODS
40 COVID-19 patients were randomly recruited in this cross-sectional study. All cases were confirmed by quantitative RT-PCR. Patients were divided into two equivalent groups, one severe and one nonsevere. Clinical, laboratory and flow cytometric data were obtained from both clinical groups and compared.
RESULTS RESULTS
Lymphocyte subsets, CD4+ and CD8+ T cells, memory CD4+ T cells, memory CD8+ T cells, naive CD4+ T cells, effector memory CD4+ T cells, central memory CD4+ T cells, and CD3+CD4+ CD25+ T cells were significantly lower in severe patients. The naive T cell/CD4 + EM T cell ratio, which is an indicator of the differentiation from naive T cells to memory cells, was relatively reduced in severe disease. Peripheral CD4+CD8+ double-positive T cells were notably lower in severe presentations of the disease (median DP T cells 11.12 µL vs 1.95 µL; p< 0.001).
CONCLUSIONS CONCLUSIONS
As disease severity increases in COVID-19 infection, the number of T cell subsets decreases significantly. Suppression of differentiation from naive T cells to effector memory T cells is the result of severe impairment in adaptive immune functions. Peripheral CD4+CD8+ double-positive T cells were significantly reduced in severe disease presentations and may be a useful marker to predict disease severity.

Identifiants

pubmed: 33331574
pii: S0104-42302020001201666
doi: 10.1590/1806-9282.66.12.1666
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1666-1672

Auteurs

Yasin Kalpakci (Y)

Medical Doctor, Department of Hematology, Sakarya University Medicine Faculty, Sakarya, Turkey.

Tuba Hacibekiroglu (T)

Associate Professor, Department of Hematology, Sakarya University Medicine Faculty, Sakarya, Turkey.

Gulay Trak (G)

Medical Doctor, Department of Microbiology, Sakarya University Medicine Faculty, Sakarya, Turkey.

Cengiz Karacaer (C)

Medical Doctor, Department of Internal Medicine, Sakarya University Medicine Faculty, Sakarya, Turkey.

Taner Demirci (T)

Assistant Professor, Department of Internal Medicine Division of Endocrinology, Sakarya University Medicine Faculty, Sakarya, Turkey.

Havva Kocayigit (H)

Medical Doctor, Department of Anesthesiology, Sakarya University Medicine Faculty, Sakarya, Turkey.

Cenk Sunu (C)

Associate Professor, Department of Internal Medicine, Sakarya University Medicine Faculty, Sakarya, Turkey.

Ceyhun Varim (C)

Medical Doctor, Department of Hematology, Duzen Laboratory Group, İstanbul, Turkey.

Mesude Falay (M)

Hematology, Ankara Numune Training and Research Hospital, Ankara, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH